Aegon UK Equity Fund GBP B AccRegister to Unlock Ratings |
Performance History | 31/10/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | -2.5 | 16.5 | -11.6 | 3.6 | 9.3 | |
+/-Cat | 6.6 | -1.5 | -9.5 | -4.7 | 1.9 | |
+/-B’mrk | - | - | - | -4.1 | 1.1 | |
Category: UK Large-Cap Equity | ||||||
Category Benchmark: Morningstar UK All Cap TME ... |
Key Stats | ||
NAV 22/11/2024 | GBX 380.38 | |
Day Change | 1.43% | |
Morningstar Category™ | UK Large-Cap Equity | |
IA (formerly IMA) Sector | UK All Companies | |
ISIN | GB0007451411 | |
Fund Size (Mil) 31/05/2022 | GBP 177.15 | |
Share Class Size (Mil) 31/10/2024 | GBP 164.04 | |
Max Initial Charge | - | |
Ongoing Charge 06/05/2024 | 0.63% |
Investment Objective: Aegon UK Equity Fund GBP B Acc |
The investment objective is to provide a combination of income and capital growth over any 7 year period. At least 80% of the Fund will be invested in equities of companies which are listed, quoted or traded in UK markets or which have their headquarters or a significant part of their activities in the UK but which may also be quoted on a regulated market outside of the UK. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Stephen Adams 01/04/2004 | ||
Philip Haworth 20/11/2015 | ||
Inception Date 12/08/1985 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
FTSE AllSh TR GBP | Morningstar UK All Cap TME NR GBP |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Aegon UK Equity Fund GBP B Acc | 30/09/2024 |
|
|
Top 5 Holdings | Sector | % |
AstraZeneca PLC | Healthcare | 8.84 |
Unilever PLC | Consumer Defensive | 7.51 |
Shell PLC | Energy | 5.65 |
Ashtead Group PLC | Industrials | 3.21 |
HSBC Holdings PLC | Financial Services | 3.12 |
Increase Decrease New since last portfolio | ||
Aegon UK Equity Fund GBP B Acc |